Related Experiment Video
Updated: Jul 20, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Machine learning approaches that use clinical, laboratory, and electrocardiogram data enhance the prediction of
Hyun-Gyu Lee1, Sang-Don Park2, Jang-Whan Bae3
1School of Medicine, Inha University, Incheon, Korea.
Insights
This study developed an ensemble model using machine learning and deep learning to predict obstructive coronary artery disease (ObCAD). The model integrates clinical, laboratory, and ECG data, outperforming traditional methods for accurate ObCAD assessment.
Area of Science:
- Cardiology
- Medical Informatics
- Machine Learning in Healthcare
Background:
- Traditional pretest probability (PTP) models for obstructive coronary artery disease (ObCAD) may overestimate risk.
- Integration of standard laboratory findings and electrocardiogram (ECG) raw data into PTP estimation requires further evaluation.
Purpose of the Study:
- To develop and evaluate an ensemble model using machine learning (ML) and deep learning (DL) for ObCAD assessment.
- To incorporate clinical, laboratory, and ECG data for improved PTP estimation.
Main Methods:
- Extracted data from electronic medical records of 7907 patients with suspected ObCAD undergoing coronary angiography (2008-2020).
- Developed an ML model using 27 clinical and laboratory variables.
- Developed a DL model using ECG waveform data.
- Combined models into an ensemble for ObCAD prediction.
Main Results:
- The clinical-laboratory model achieved an AUC of 0.747.
- The ECG model achieved an AUC of 0.685.
- The ensemble model demonstrated the highest AUC of 0.767, with sensitivity, specificity, and F1 score of 0.761, 0.625, and 0.696, respectively.
Conclusions:
- The ensemble model shows superior predictive performance for ObCAD compared to traditional PTP models.
- This approach may enable personalized ObCAD assessment and reduce overestimation of pretest probability.
- Integration of ML/DL with clinical, laboratory, and ECG data offers a promising strategy for cardiovascular risk stratification.
Abstract:
Pretest probability (PTP) for assessing obstructive coronary artery disease (ObCAD) was updated to reduce overestimation. However, standard laboratory findings and electrocardiogram (ECG) raw data as first-line tests have not been evaluated for integration into the PTP estimation. Therefore, this study developed an ensemble model by adopting machine learning (ML) and deep learning (DL) algorithms with clinical, laboratory, and ECG data for the assessment of ObCAD. Data were extracted from the electronic medical records of patients with suspected ObCAD who underwent coronary angiography. With the ML algorithm, 27 clinical and laboratory data were included to identify ObCAD, whereas ECG waveform data were utilized with the DL algorithm. The ensemble method combined the clinical-laboratory and ECG models. We included 7907 patients between 2008 and 2020. The clinical and laboratory model showed an area under the curve (AUC) of 0.747; the ECG model had an AUC of 0.685. The ensemble model demonstrated the highest AUC of 0.767. The sensitivity, specificity, and F1 score of the ensemble model ObCAD were 0.761, 0.625, and 0.696, respectively. It demonstrated good performance and superior prediction over traditional PTP models. This may facilitate personalized decisions for ObCAD assessment and reduce PTP overestimation.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease II: Pathophysiology